FI102181B1 - Process for obtaining ICAM-1 (intermolecular adhesion molecules) in substantially pure form - Google Patents

Process for obtaining ICAM-1 (intermolecular adhesion molecules) in substantially pure form

Info

Publication number
FI102181B1
FI102181B1 FI902490A FI902490A FI102181B1 FI 102181 B1 FI102181 B1 FI 102181B1 FI 902490 A FI902490 A FI 902490A FI 902490 A FI902490 A FI 902490A FI 102181 B1 FI102181 B1 FI 102181B1
Authority
FI
Finland
Prior art keywords
icam
obtaining
substantially pure
pure form
adhesion molecules
Prior art date
Application number
FI902490A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI902490A0 (en
FI102181B (en
Inventor
Timothy A Springer
Robert Rothlein
Steven D Marlin
Michael L Dustin
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of FI902490A0 publication Critical patent/FI902490A0/en
Application granted granted Critical
Publication of FI102181B1 publication Critical patent/FI102181B1/en
Publication of FI102181B publication Critical patent/FI102181B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI902490A 1988-09-28 1990-05-21 Process for obtaining ICAM-1 (intermolecular adhesion molecules) in substantially pure form FI102181B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25044688A 1988-09-28 1988-09-28
US25044688 1988-09-28
US37388289A 1989-06-30 1989-06-30
US37388289 1989-06-30
US8904242 1989-09-28
PCT/US1989/004242 WO1990003400A1 (en) 1988-09-28 1989-09-28 Intercellular adhesion molecules, and their binding ligands

Publications (3)

Publication Number Publication Date
FI902490A0 FI902490A0 (en) 1990-05-21
FI102181B1 true FI102181B1 (en) 1998-10-30
FI102181B FI102181B (en) 1998-10-30

Family

ID=26940882

Family Applications (2)

Application Number Title Priority Date Filing Date
FI902490A FI102181B (en) 1988-09-28 1990-05-21 Process for obtaining ICAM-1 (intermolecular adhesion molecules) in substantially pure form
FI981097A FI107451B (en) 1988-09-28 1998-05-18 A method for obtaining ICAM-1 (intercellular adhesion molecule) in substantially pure form

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI981097A FI107451B (en) 1988-09-28 1998-05-18 A method for obtaining ICAM-1 (intercellular adhesion molecule) in substantially pure form

Country Status (7)

Country Link
JP (1) JP2976381B2 (en)
KR (1) KR900701846A (en)
AU (2) AU4412889A (en)
DK (1) DK175362B1 (en)
FI (2) FI102181B (en)
HU (1) HU218904B (en)
WO (1) WO1990003400A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
DK0391088T3 (en) * 1989-03-16 1997-06-16 Blood Res Center Use of functional derivatives of the intercellular adhesion molecule ICAM-1 for antiviral therapy
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
WO1991018011A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof
DK162890D0 (en) * 1990-07-06 1990-07-06 Novo Nordisk As POLYPEPTIDE
US5871733A (en) * 1990-07-20 1999-02-16 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US5674982A (en) * 1990-07-20 1997-10-07 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5283058A (en) 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
CA2056143A1 (en) * 1990-11-28 1992-05-29 Michael S. Diamond The mac-1 binding site of icam-1
US5932214A (en) * 1994-08-11 1999-08-03 Biogen, Inc. Treatment for inflammatory bowel disease with VLA-4 blockers
US5599790A (en) 1992-06-11 1997-02-04 The Scripps Research Institute Fibrinogen γ chain polypeptide and compositions thereof
DK0644768T3 (en) * 1992-06-11 2002-05-21 Scripps Research Inst Methods and preparations for inhibiting endothelial cell and fibrinogen-induced inflammation
JPH08502956A (en) * 1992-10-09 1996-04-02 センター、フォー、ブラッド、リサーチ、インコーポレーテッド Subpopulation of Mac-1 (CD11b / CD18) molecules that mediate neutrophil adhesion to ICAM-1 and fibrinogen
DE4335273A1 (en) * 1993-10-15 1995-04-20 Univ Ludwigs Albert Peptides for tumor therapy
WO1995028170A1 (en) * 1994-04-19 1995-10-26 The University Of Kansas Icam-1/lfa-1 short-chain peptides and method of using same
WO1997000956A1 (en) * 1995-06-20 1997-01-09 Trustees Of Boston University Hypoxia-responsive adhesion molecules, specific antibodies, and their uses
ATE296668T1 (en) * 1999-09-01 2005-06-15 Boehringer Ingelheim Pharma COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES CONTAINING AGENTS THAT INHIBIT ICAM-1/LFA-1 INTERACTIONS AND AGENTS THAT INHIBIT CD40-CD40 LIGAND INTERACTIONS
DK1682537T3 (en) 2003-11-05 2012-07-09 Sarcode Bioscience Inc Cell adhesion modulators
PL2444079T3 (en) 2005-05-17 2017-07-31 Sarcode Bioscience Inc. Compositions and Methods for Treatment of Eye Disorders
CA2702984C (en) 2007-10-19 2017-04-11 Sarcode Corporation Compositions and methods for treatment of diabetic retinopathy
EP2853544A1 (en) * 2007-11-15 2015-04-01 Chugai Seiyaku Kabushiki Kaisha Monoclonal antibody capable of binding to anexelekto, and use thereof
US8080562B2 (en) 2008-04-15 2011-12-20 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
US8378105B2 (en) 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
IN2015DN00847A (en) 2012-07-25 2015-06-12 Sarcode Bioscience Inc
JP7166342B2 (en) 2017-11-30 2022-11-07 エフ．ホフマン－ラ ロシュ アーゲー B cell culture method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080044T3 (en) * 1987-05-04 1996-02-01 Dana Farber Cancer Inst Inc INTERCELLULAR ADHESION MOLECULES AND THEIR FIXATION LINKS.
EP0314863B1 (en) * 1987-11-02 1994-12-07 Baylor College Of Medicine Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation

Also Published As

Publication number Publication date
DK175362B1 (en) 2004-09-13
DK128990A (en) 1990-07-26
AU4412889A (en) 1990-04-18
FI902490A0 (en) 1990-05-21
AU679506B2 (en) 1997-07-03
DK128990D0 (en) 1990-05-25
FI981097A0 (en) 1989-09-28
FI981097A (en) 1998-05-18
JPH03501861A (en) 1991-04-25
FI107451B (en) 2001-08-15
HU896074D0 (en) 1990-11-28
FI102181B (en) 1998-10-30
AU6319294A (en) 1994-08-25
KR900701846A (en) 1990-12-04
HUT56120A (en) 1991-07-29
WO1990003400A1 (en) 1990-04-05
HU218904B (en) 2000-12-28
JP2976381B2 (en) 1999-11-10

Similar Documents

Publication Publication Date Title
FI102181B1 (en) Process for obtaining ICAM-1 (intermolecular adhesion molecules) in substantially pure form
GB8803574D0 (en) Improvements in/relating to stretch films
IT1201075B (en) METHOD AND APPARATUS FOR POSITIONING CLOTH ITEMS
DE3675080D1 (en) METHOD FOR PRODUCING GRAPHITE FILMS.
ATA260986A (en) METHOD FOR PRODUCING CEFUROXIMAXETIL FILM TABLETS
FI101309B1 (en) Polymer composition for removing oxygen
DE68917625D1 (en) Composite material and process for its manufacture.
NO902454D0 (en) MOUNTAIN CARD FOR FITTING IN THE REAR PLAN OF A SHORT FRAME
DE3879536T3 (en) Superconducting ceramic film and process for its production.
DE3788294T2 (en) Process and device for film production.
FI895562A0 (en) Process for producing (S) -ethyl-2-oxo-1-pyrrolidine acetamide
FI894005A0 (en) Process for concentrating solutions
DE3877851D1 (en) DEVICE FOR ATTACHING REINFORCEMENT FILMS TO ZIPPER CHAINS.
DE69005561D1 (en) Ceramic plate with inlaid ornament and process for its production.
DE3782330T2 (en) BACK SUCTION PROCESS IN INJECTION MOLDING SYSTEM.
YU124289A (en) Process for obtaining alumoxane in waterless solution
ATE83466T1 (en) METHOD AND APPARATUS FOR MAKING PICTURE POSTCARDS.
GR900300096T1 (en) Adhesive for plastics, and process for using this adhesive
DK110987A (en) PROCEDURE AND APPARATUS FOR EFFECTING THE BASIC PRODUCT BY FINDING IN WHEELS
GB2222994B (en) Improvements in or relating to conveying apparatus
DE68921893D1 (en) PROCESS FOR ELECTRICITY SUPPLY.
DE68912907D1 (en) Process for manufacturing clad panels and panels made in this way.
FR2633614B1 (en) PROCESS FOR MONOHALOGENATION IN (ALPHA) OF THE CARBONYL GROUPS OF THE KETONES
GB8811557D0 (en) Improvements in/relating to article labelling apparatus
NO933877D0 (en) PROCEDURE FOR AA PREVENT BLOCK IN CATHETERS

Legal Events

Date Code Title Description
FG Patent granted

Owner name: DANA FARBER CANCER INSTITUTE